Juul Paying Scientists to Prove Safety of E-Cigs

According to a story in the New York Times, Juul Labs is aggressively recruiting scientists to prove to the Food and Drug Administration, and to the public, that e-cigarettes offer more public health benefit than risk. If it fails to submit proper evidence by 2022, the agency could halt all sales.
An assistant professor of physiology at the University of Louisville medical school, was reportedly approached by a medical liaison for Juul who said collaborating with the company could be worth up to $200,000.

Juul recently launched a science website promoting its research grants. So far, Juul has reported funding studies only by the Centre for Substance Use Research, based in Scotland, and collaborating with a few independent labs. The Glasgow organization, which has done most of Juul’s outside research, is well known to tobacco control advocates, who have long criticized its studies for playing down the danger of youth addiction to e-cigarettes

Recent Articles

When Steph Sherer founded the ASA in 2002, she never expected she’d still be doing this work more than 20 years later. A recent college graduate living in Southern California, she was also taking a high dose of anti-inflammatories every day for a painful chronic injury. And despite her young age, she was experiencing early onset kidney failure because of it.
Given the popularity of its products, it’s odd that America’s cannabis industry feels so brittle. Smoke shops seem to teeter on the edge of annihilation due to a constellation of government and societal pressures.
Explore the art of flirtatious sales, discover how charm and confidence can close deals successfully, all using the C-Word!
While only two states, Oregon and Colorado, have legalized psilocybin and a few other psychedelics, many other states are nipping at their heels with their own legislation pending.
Believe it or not, some head shops and vape stores have yet to fully realize the benefits of technology. Many brick-and-mortar establishments still follow the “if it ain’t broke, don’t fix it” mentality, and they want to keep it that way.
As the FDA began issuing denials, Vapetasia CEO Chris Finch started planning. He knew the next step was to sue the FDA, but he also knew it would take money, manpower, and risk.
Running a head shop in the modern day doesn’t mean you can’t take advantage of the latest and greatest business tech.
Explore the art of flirtatious sales and discover how charm and confidence can close deals successfully.